Ongoing legal challenges to the U.S. Food and Drug Administration’s (FDA’s) approval of mifepristone (200 mg) have created confusion nationwide about the status of the drug and access to medication management of abortion and early pregnancy loss. As ACOG members continue providing patient care during this time, we understand that both they and their patients have questions. These FAQs have been developed to address questions as they arise in this evolving legal and political landscape. They are based on evidence-informed practice and expert opinion and are intended to supplement the following ACOG documents: Practice Bulletin No. 225, Medication Abortion Up to 70 Days of Gestation, originally published in October 2020; Practice Bulletin No. 200, Early Pregnancy Loss, originally published in November 2018; Committee Opinion No. 815, Increasing Access to Abortion, originally published in December 2020; and Practice Advisory: Updated Mifepristone REMS Requirements, originally published online in January 2023.

This is a rapidly changing landscape, and FAQs will be added or modified on a regular basis as additional information becomes available.

Frequently Asked Questions

The American College of Obstetricians and Gynecologists recognizes and supports the gender diversity of all patients who seek obstetric and gynecologic care. In original portions of this document, authors seek to use gender-inclusive language or gender-neutral language. When describing research findings, this document uses gender terminology reported by investigators. To review ACOG’s policy on inclusive language, see

This information is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care, and use of this information is voluntary. It does not constitute legal advice; clinicians should be familiar with and comply with federal, state, and local restrictions on abortion, including medication abortion, and are encouraged to consult with a lawyer when navigating local abortion laws and regulations. This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. It is not intended to substitute for the independent professional judgment of the treating clinician. Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. The American College of Obstetricians and Gynecologists reviews its publications regularly; however, its publications may not reflect the most recent evidence. Any updates to this document can be found on

While ACOG makes every effort to present accurate and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. ACOG does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither ACOG nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented.

Publications of the American College of Obstetrician and Gynecologists are protected by copyright and all rights are reserved. The College’s publications may not be reproduced in any form or by any means without written permission from the copyright owner.

The American College of Obstetricians and Gynecologists (ACOG) is the nation’s leading group of physicians providing evidence-based obstetric and gynecologic care. As a private, voluntary, nonprofit membership organization of more than 60,000 members, ACOG strongly advocates for equitable, exceptional, and respectful care for all women and people in need of obstetric and gynecologic care; maintains the highest standards of clinical practice and continuing education of its members; promotes patient education; and increases awareness among its members and the public of the changing issues facing patients and their families and communities.